Ads
related to: drugmaker- Locations
State-of-the-art drug manufacturing
facilities and expertise. UK & US.
- Analytical Services
Candidate screening
Analytical development
- Contact
Contact our experts about your
drug development programs & needs
- Formulation Design
Variety of dosage forms
Oral, inhaled, topical & more
- Events
Meet our experts at global events.
Schedule a meeting with us.
- First-In-Human
Best formulation for First-In-Human
Experience in various formats
- Locations
Search results
As Zepbound shortage grows, Eli Lilly says no immediate end is in sight
NBC News via Yahoo News· 3 hours agoZepbound drugmaker Eli Lilly is working to increase its weight loss drug supply. But some steps to...
Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says
CNN.com· 16 hours agoZepbound, a popular weight loss drug, also seems to help people with obstructive sleep apnea, ...
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 12 minutes agoPfizer stock is trading at a nine-year low as the drugmaker looks for its next big break after...
France Might Block Drugmaker Biogaran’s Sale to Foreign Firm
Bloomberg· 1 hour agoThe French government might block a foreign company from buying generic-drug maker Biogaran,...
GSK says efficacy of its shingles vaccine remains high after years
Reuters via Yahoo News· 1 day ago(Reuters) - British drugmaker GSK said on Wednesday long-term data showed that its blockbuster...
Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?
Motley Fool via Yahoo Finance· 3 hours agoBiotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) continues to grab headlines. Over the past six...
Employers feel the side effects of drugmaker control over Wegovy, Ozempic costs
Politico via Yahoo Finance· 7 hours agoWhat happened in North Carolina is playing out across the U.S. as large employers try to limit the...
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
New York Times· 2 hours agoThe company has told countries that it can supply only 18.8 million of the 29.6 million doses it was...
No more $35 insulin cap? Eli Lilly, plaintiffs call off $13.5M class action settlement
BenefitsPRO· 56 minutes agoA settlement between the drugmaker and insulin patients that would have capped patients'...
AbbVie-bound Cerevel reports phase 3 Parkinson's victory in early win for $8.7B deal
FierceBiotech· 3 hours agoThe backing singer in AbbVie’s $8.7 billion takeover of Cerevel Therapeutics is having its moment in...
